The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Congress 2024 | Managing cardiovascular risks in patients with CHIP and MPNs: insights from a cardiologist
Stephanie Feldman, MD, Weill Cornell Medicine, New York City, NY, provides an overview of the cardiovascular risks associated with clonal hematopoiesis of indeterminate potential (CHIP) and myeloproliferative neoplasms (MPNs). Dr Feldman emphasizes the lack of specific guidelines for managing these patients, and introduces a mnemonic (ABCDE) to help oncologists address cardiovascular risk factors in this high-risk population. This interview took place virtually as part of the 16th International Congress on Myeloproliferative Neoplasms (MPNs) in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
